1. Home
  2. OCS vs SHEN Comparison

OCS vs SHEN Comparison

Compare OCS & SHEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • SHEN
  • Stock Information
  • Founded
  • OCS 2003
  • SHEN 1902
  • Country
  • OCS Switzerland
  • SHEN United States
  • Employees
  • OCS N/A
  • SHEN N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • SHEN Telecommunications Equipment
  • Sector
  • OCS Health Care
  • SHEN Telecommunications
  • Exchange
  • OCS Nasdaq
  • SHEN Nasdaq
  • Market Cap
  • OCS 689.8M
  • SHEN 626.7M
  • IPO Year
  • OCS N/A
  • SHEN N/A
  • Fundamental
  • Price
  • OCS $18.76
  • SHEN $11.68
  • Analyst Decision
  • OCS Strong Buy
  • SHEN Strong Buy
  • Analyst Count
  • OCS 4
  • SHEN 1
  • Target Price
  • OCS $30.25
  • SHEN $26.00
  • AVG Volume (30 Days)
  • OCS 28.7K
  • SHEN 275.4K
  • Earning Date
  • OCS 05-20-2025
  • SHEN 04-30-2025
  • Dividend Yield
  • OCS N/A
  • SHEN 0.85%
  • EPS Growth
  • OCS N/A
  • SHEN N/A
  • EPS
  • OCS N/A
  • SHEN N/A
  • Revenue
  • OCS $757,024.00
  • SHEN $346,708,000.00
  • Revenue This Year
  • OCS $49.27
  • SHEN $13.41
  • Revenue Next Year
  • OCS $1,920.31
  • SHEN $7.69
  • P/E Ratio
  • OCS N/A
  • SHEN N/A
  • Revenue Growth
  • OCS N/A
  • SHEN 27.84
  • 52 Week Low
  • OCS $10.79
  • SHEN $9.77
  • 52 Week High
  • OCS $23.08
  • SHEN $21.89
  • Technical
  • Relative Strength Index (RSI)
  • OCS 57.04
  • SHEN 44.61
  • Support Level
  • OCS $18.01
  • SHEN $10.95
  • Resistance Level
  • OCS $19.50
  • SHEN $11.99
  • Average True Range (ATR)
  • OCS 0.72
  • SHEN 0.71
  • MACD
  • OCS 0.18
  • SHEN -0.11
  • Stochastic Oscillator
  • OCS 76.19
  • SHEN 54.76

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through two business units: tower and broadband. The tower segment leases company-owned cell tower spaces to other wireless communication providers, while the broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

Share on Social Networks: